Requires pharmacies to provide prescription drug readers or other means of access to individuals who disclose they have difficulty seeing or reading standard print labels on prescription drug containers; defines "prescription drug reader" to mean a device which is capable of audibly conveying information contained on the label of a prescription drug; makes exceptions.
Same As
Requires pharmacies to provide prescription drug readers or other means of access to individuals who disclose they have difficulty seeing or reading standard print labels on prescription drug containers; defines "prescription drug reader" to mean a device which is capable of audibly conveying information contained on the label of a prescription drug; makes exceptions.
Requires pharmacies to provide prescription drug readers or other means of access to individuals who disclose they have difficulty seeing or reading standard print labels on prescription drug containers; defines "prescription drug reader" to mean a device which is capable of audibly conveying information contained on the label of a prescription drug; makes exceptions.
Requires prescription drug containers be labeled with a description of the size, shape, color and imprint of the prescription drug it contains if such drug is in tablet or capsule form.
Enacts the "foreign drug transparency act" to provide information on the origin, manufacture and distribution of prescription drugs; requires a pharmacy benefit manager to maintain, and make available to pharmacies, health plans, and patients upon request, supply chain information for prescription drugs covered under its network.
Enacts the "foreign drug transparency act" to provide information on the origin, manufacture and distribution of prescription drugs; requires a pharmacy benefit manager to maintain, and make available to pharmacies, health plans, and patients upon request, supply chain information for prescription drugs covered under its network.
Prescriptions for testosterone not allowed to be transmitted or reported within the prescription drug monitoring database and removes from the records all existing information concerning prior testosterone prescriptions.
Prescriptions for testosterone not allowed to be transmitted or reported within the prescription drug monitoring database and removes from the records all existing information concerning prior testosterone prescriptions.
Increases the maximum fill for non-opioid, non-narcotic controlled substances found in schedule II, so that a sixty-day (60) supply may be dispensed at any one time.
Increases the maximum fill for non-opioid, non-narcotic controlled substances found in schedule II, so that a ninety-day (90) supply may be dispensed at any one time.